Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A Infection

NCT03834376 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

H7N9 Subtype of Influenza A Virus

Interventions

DRUG: Pimodivir

Sponsor

Janssen Research & Development, LLC